179 related articles for article (PubMed ID: 11775454)
1. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.
Mills GB; Eder A; Fang X; Hasegawa Y; Mao M; Lu Y; Tanyi J; Tabassam FH; Wiener J; Lapushin R; Yu S; Parrott JA; Compton T; Tribley W; Fishman D; Stack MS; Gaudette D; Jaffe R; Furui T; Aoki J; Erickson JR
Cancer Treat Res; 2002; 107():259-83. PubMed ID: 11775454
[TBL] [Abstract][Full Text] [Related]
2. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.
Fang X; Gaudette D; Furui T; Mao M; Estrella V; Eder A; Pustilnik T; Sasagawa T; Lapushin R; Yu S; Jaffe RB; Wiener JR; Erickson JR; Mills GB
Ann N Y Acad Sci; 2000 Apr; 905():188-208. PubMed ID: 10818454
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer.
Schulte KM; Beyer A; Köhrer K; Oberhäuser S; Röher HD
Int J Cancer; 2001 Apr; 92(2):249-56. PubMed ID: 11291053
[TBL] [Abstract][Full Text] [Related]
5. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors.
Hama K; Bandoh K; Kakehi Y; Aoki J; Arai H
FEBS Lett; 2002 Jul; 523(1-3):187-92. PubMed ID: 12123830
[TBL] [Abstract][Full Text] [Related]
8. [Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers].
Tanyi J; Rigó J
Orv Hetil; 2009 Jun; 150(24):1109-18. PubMed ID: 19739275
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.
An S; Bleu T; Zheng Y; Goetzl EJ
Mol Pharmacol; 1998 Nov; 54(5):881-8. PubMed ID: 9804623
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
[TBL] [Abstract][Full Text] [Related]
11. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
Takuwa Y; Takuwa N; Sugimoto N
J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
[TBL] [Abstract][Full Text] [Related]
12. Analysis of lysophosphatidic acid (LPA) receptor and LPA-induced endometrial prostaglandin-endoperoxide synthase 2 expression in the porcine uterus.
Seo H; Kim M; Choi Y; Lee CK; Ka H
Endocrinology; 2008 Dec; 149(12):6166-75. PubMed ID: 18703629
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
Bandoh K; Aoki J; Taira A; Tsujimoto M; Arai H; Inoue K
FEBS Lett; 2000 Jul; 478(1-2):159-65. PubMed ID: 10922489
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
16. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
Goetzl EJ; Dolezalova H; Kong Y; Hu YL; Jaffe RB; Kalli KR; Conover CA
Cancer Res; 1999 Oct; 59(20):5370-5. PubMed ID: 10537322
[TBL] [Abstract][Full Text] [Related]
17. Non-Edg family lysophosphatidic acid (LPA) receptors.
Ishii S; Noguchi K; Yanagida K
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):57-65. PubMed ID: 19524700
[TBL] [Abstract][Full Text] [Related]
18. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid is a bioactive mediator in ovarian cancer.
Fang X; Schummer M; Mao M; Yu S; Tabassam FH; Swaby R; Hasegawa Y; Tanyi JL; LaPushin R; Eder A; Jaffe R; Erickson J; Mills GB
Biochim Biophys Acta; 2002 May; 1582(1-3):257-64. PubMed ID: 12069836
[TBL] [Abstract][Full Text] [Related]
20. EDG receptors and hepatic pathophysiology of LPA and S1P: EDG-ology of liver injury.
Svetlov SI; Sautin YY; Crawford JM
Biochim Biophys Acta; 2002 May; 1582(1-3):251-6. PubMed ID: 12069835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
